Off-Label Menu & Personalization
Medium
Whether an off-label longevity menu (rapamycin, metformin, low-dose naltrexone) is personalized with labs — or run as a one-size protocol mill.
Why it matters
Off-label longevity prescribing can be responsible or reckless. Lab-driven personalization is the marker of the former; a protocol handed to everyone is the marker of a mill.
How we assess it
We check whether off-label prescribing is individualized.
- Rapamycin / metformin / LDN and other off-label options
- Labs-driven personalization vs. a fixed protocol for all
Source types: The provider’s treatment menu and described personalization process.
How we score it
A labs-personalized approach scores high. A protocol-mill handing the same stack to everyone is the red flag and scores lower.
- Importance
- Medium
Medium — a moderate weight within NAD+.
- Scope
- Anti-Aging / NAD+ overlay
What this tier is worth
Tiers carry fixed weights: Critical 5, High 3, Medium 2, Supporting 1. A score is the weighted mean of the factors we could establish, so you can recompute any of ours by hand — the methodology page works one through end to end.
Not medical advice
This factor rates how openly a provider discloses its process — not whether a treatment is right for you. That decision belongs with a licensed clinician who knows your history. Nothing here is medical advice.
- Scope
- Anti-Aging / NAD+ overlay
How this shows up in real reviews
Cited evidence we captured on this factor in live provider reviews.